$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
11:55am, Friday, 02'nd May 2025
Positive jobs news and positive rumors out of China are lifting stock markets today, as the U.S. Labor Department reports adjusted nonfarm payrolls grew by 177,000 jobs in April, and CNBC reports that
Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why.
11:53am, Friday, 02'nd May 2025
Analysts were rushing to reiterate their conviction in the stock following Thursday's blow to Zepbound and Lilly shares.
Lilly to participate in Bank of America Securities 2025 Healthcare Conference
10:00am, Friday, 02'nd May 2025
INDIANAPOLIS , May 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Bank of America Securities 2025 Healthcare Conference, May 15, 2025. Lucas Montarce, Lilly executive
Eli Lilly's worst day in nearly 17 years: Strategist Jared Holz on Q1 results
05:45pm, Thursday, 01'st May 2025
Jared Holz, Mizuho Securities health care strategist, joins 'Fast Money' to discuss Eli Lilly's biggest day drop since 2008 and the obesity drug competition.
Eli Lilly and Company (LLY) Q1 2025 Earnings Call Transcript
02:17pm, Thursday, 01'st May 2025
Eli Lilly and Company (NYSE:LLY ) Q1 2025 Results Conference Call May 1, 2025 10:00 AM ET Company Participants Mike Czapar - Senior Vice President of Investor Relations Dave Ricks - Chair and CEO Luca
Kohl's Jumps After Firing CEO, Eli Lilly Tumbles, Microsoft Soars | Stock Movers Podcast
02:10pm, Thursday, 01'st May 2025
Get more equity coverage like this on the Stock Movers podcast from Bloomberg, featuring five-minute episodes on the winners and losers in the stock market. Subscribe here: https://link.podtrac.com/h0
CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone
01:56pm, Thursday, 01'st May 2025
Eli Lilly and Company's stock fell over 11% after CVS Caremark excluded Lilly's obesity drug Zepbound from its standard commercial formularies starting July 1, 2025. The market overreacted to CVS's ex
Eli Lilly earnings topped estimates, so why the stock is sinking?
12:58pm, Thursday, 01'st May 2025
Eli Lilly (LLY) shares slid at the open despite topping first quarter estimates, with investors reacting to the company lowering its full-year profit outlook. Investors are also reacting to a new deal
LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down
12:55pm, Thursday, 01'st May 2025
Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat estimates.
Why Eli Lilly Stock Is Sinking Today
12:49pm, Thursday, 01'st May 2025
Shares of Eli Lilly (LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m.
Initial Claims More Than Expectations
12:10pm, Thursday, 01'st May 2025
Initial Claims More Than Expectations.
Eli Lilly CEO David Ricks on pricing of the new weight loss pill if approved
12:00pm, Thursday, 01'st May 2025
Eli Lilly chairman and CEO David Ricks discusses the status of the company's weight loss drug pill.
Jobless Claims Higher; Q1 Earnings from LLY, MCD & More
11:35am, Thursday, 01'st May 2025
Last week, 241K Americans filed for unemployment on Initial Jobless Claims, with Continuing Claims touching 1.9 million.
Here's What Key Metrics Tell Us About Lilly (LLY) Q1 Earnings
10:36am, Thursday, 01'st May 2025
The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
QCOM Earnings Sell-Off, CVS Turnaround Continues, LLY Disappoints
10:30am, Thursday, 01'st May 2025
While Microsoft (MSFT) and Meta Platforms (META) shined in the Big Tech space, Diane King Hall turns to a mixed earnings picture elsewhere on Wall Street. CVS Health (CVS) posted an earnings beat, rai
Sign In
Buy LLY